Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125550693 | 12555069 | 3 | F | 20150616 | 20160825 | 20160714 | 20160831 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-023090 | BRISTOL MYERS SQUIBB | 88.00 | YR | F | Y | 0.00000 | 20160831 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125550693 | 12555069 | 1 | PS | DACLATASVIR DIHYDROCHLORIDE | DACLATASVIR DIHYDROCHLORIDE | 1 | Unknown | 60 MG, QD | 206843 | 60 | MG | FILM-COATED TABLET | QD | ||||||
| 125550693 | 12555069 | 2 | SS | DACLATASVIR DIHYDROCHLORIDE | DACLATASVIR DIHYDROCHLORIDE | 1 | Unknown | 60 UNK, QD | 206843 | 60 | MG | FILM-COATED TABLET | QD | ||||||
| 125550693 | 12555069 | 3 | SS | ASUNAPREVIR | ASUNAPREVIR | 1 | Unknown | 100 MG, BID | 0 | 100 | MG | FILM-COATED TABLET | BID | ||||||
| 125550693 | 12555069 | 4 | SS | ASUNAPREVIR | ASUNAPREVIR | 1 | Unknown | 100 MG, QD | 0 | 100 | MG | FILM-COATED TABLET | QD | ||||||
| 125550693 | 12555069 | 5 | SS | ASUNAPREVIR | ASUNAPREVIR | 1 | Unknown | 100 MG, UNK | 0 | 100 | MG | FILM-COATED TABLET | BID | ||||||
| 125550693 | 12555069 | 6 | SS | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | 2.5 MG, QD | U | 0 | 2.5 | MG | QD | ||||||
| 125550693 | 12555069 | 7 | C | MAINTATE | BISOPROLOL FUMARATE | 1 | Oral | 1.25 MG, QD | U | 0 | 1.25 | MG | QD | ||||||
| 125550693 | 12555069 | 8 | C | MAINTATE | BISOPROLOL FUMARATE | 1 | Unknown | 2.5 UNK, UNK | U | 0 | 2.5 | MG | QD | ||||||
| 125550693 | 12555069 | 9 | C | MAINTATE | BISOPROLOL FUMARATE | 1 | Unknown | 5 UNK, UNK | U | 0 | 5 | MG | QD | ||||||
| 125550693 | 12555069 | 10 | C | XARELTO | RIVAROXABAN | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 125550693 | 12555069 | 11 | C | FEBURIC | FEBUXOSTAT | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 125550693 | 12555069 | 12 | C | DIART | AZOSEMIDE | 1 | Oral | 60 MG, QD | U | 0 | 60 | MG | QD | ||||||
| 125550693 | 12555069 | 13 | C | HANP | CARPERITIDE | 1 | Oral | 1000 ?G, QD | U | 0 | 1000 | UG | QD | ||||||
| 125550693 | 12555069 | 14 | C | SAMSCA | TOLVAPTAN | 1 | Unknown | 15 MG, QD | U | 0 | 15 | MG | QD | ||||||
| 125550693 | 12555069 | 15 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 60 MG, QD | U | 0 | 60 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125550693 | 12555069 | 1 | Chronic hepatitis C |
| 125550693 | 12555069 | 3 | Chronic hepatitis C |
| 125550693 | 12555069 | 6 | Product used for unknown indication |
| 125550693 | 12555069 | 7 | Product used for unknown indication |
| 125550693 | 12555069 | 10 | Product used for unknown indication |
| 125550693 | 12555069 | 11 | Product used for unknown indication |
| 125550693 | 12555069 | 12 | Product used for unknown indication |
| 125550693 | 12555069 | 13 | Product used for unknown indication |
| 125550693 | 12555069 | 14 | Product used for unknown indication |
| 125550693 | 12555069 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125550693 | 12555069 | HO |
| 125550693 | 12555069 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125550693 | 12555069 | Cardiac failure | |
| 125550693 | 12555069 | Cellulitis | |
| 125550693 | 12555069 | Off label use | |
| 125550693 | 12555069 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125550693 | 12555069 | 1 | 20150421 | 0 | ||
| 125550693 | 12555069 | 2 | 20150421 | 0 | ||
| 125550693 | 12555069 | 3 | 20150421 | 20150615 | 0 | |
| 125550693 | 12555069 | 4 | 20150616 | 20150727 | 0 | |
| 125550693 | 12555069 | 5 | 20150728 | 20151006 | 0 | |
| 125550693 | 12555069 | 6 | 20160121 | 0 | ||
| 125550693 | 12555069 | 7 | 20160105 | 20160105 | 0 | |
| 125550693 | 12555069 | 8 | 20160106 | 20160118 | 0 | |
| 125550693 | 12555069 | 9 | 20160119 | 20160120 | 0 | |
| 125550693 | 12555069 | 10 | 20160105 | 0 | ||
| 125550693 | 12555069 | 11 | 20160105 | 0 | ||
| 125550693 | 12555069 | 12 | 20160105 | 20160119 | 0 | |
| 125550693 | 12555069 | 13 | 20160120 | 20160201 | 0 | |
| 125550693 | 12555069 | 14 | 20160127 | 0 | ||
| 125550693 | 12555069 | 15 | 20160307 | 0 |